Multiple missed days Missing one day is no big deal
Jalleh RJ, Jones KL, Rayner CK, Marathe CS, Wu T, Horowitz M
Your provider determines whether treatment is clinically appropriate before anything is prescribed and will tell you honestly if it is not
Patients with type 2 diabetes, especially those with cardiovascular disease, chronic kidney disease, obesity, or NAFLD, may benefit from GLP-1 receptor agonists as part of their treatment regimen
If you have any concerns, speak to a healthcare professional. Medications include: GLP-1 therapy (glucagon-like peptide-1 receptor agonists) Liraglutide as Saxenda and Semaglutide as Wegovy
Some patients experience temporary changes in hunger signals or weight stability during this period, which is expected and temporary